logo
HIV infection among persons who inject drugs
Co-delivery of HIV-1 entry inhibitor and nonnucleoside reverse transcriptase inhibitor shuttled by nanoparticles
Mitochondrial injury and cognitive function in HIV infection and methamphetamine use
c-SRC protein tyrosine kinase regulates early HIV-1 infection post-entry
Vulvar intraepithelial neoplasia
A 48-week randomized phase 2b study evaluating cenicriviroc versus efavirenz in treatment-naive HIV-infected adults with C-C chemokine receptor type 5-tropic virus
The impact of transient combination antiretroviral treatment in early HIV infection on viral suppression and immunologic response in later treatment
Prevalence of and progression to abnormal noninvasive markers of liver disease (aspartate aminotransferase-to-platelet ratio index and Fibrosis-4) among US HIV-infected youth
CD4+/CD8+ ratio, age, and risk of serious noncommunicable diseases in HIV-infected adults on antiretroviral therapy
Steroids are a risk factor for Kaposi's sarcoma-immune reconstitution inflammatory syndrome and mortality in HIV infection
Tenofovir clearance is reduced in HIV-positive patients with subclinical tubular impairment
sCD14 is not a bona-fide biomarker of microbial translocation in HIV-1-infected Africans living in Belgium
Factors associated with initiation of antiretroviral therapy among HIV-positive people who use injection drugs in a Canadian setting
The population impact of eliminating homelessness on HIV viral suppression among people who use drugs
HIV testing, risk perception, and behaviour in the British population
Comparative cost-effectiveness of Option B+ for prevention of mother-to-child transmission of HIV in Malawi
New perspectives on nanotechnology and antiretroviral drugs
No selection of CXCR4-using variants in cell reservoirs of dual-mixed HIV-infected patients on suppressive maraviroc therapy
Strengthening universal HIV ‘test-and-treat’ approaches with social science research
Raltegravir is safely used with long-term viral suppression for HIV-infected patients on hemodialysis
Subdominant Gag-specific anti-HIV efficacy in an HLA-B*57-positive elite controller